Atrial Fibrillation

>

Latest News

/ image credit internal bleeding ©Artur/stock.adobe.com
Concomitant SSRI and DOAC Use Increases Risk of Major Bleeding, Including ICH: New Findings

March 25th 2024

Overall, a 33% increased risk of major bleeding was seen, with risk highest during the first 30 days of concomitant use and persistent, but lower, after 6 months.

Apixaban and Aspirin Equal in Preventing Stroke Recurrence in Cardiopathy: Daily Dose / image credit: ©New Africa/AdobeStock
Apixaban and Aspirin Equal in Preventing Stroke Recurrence in Cardiopathy: Daily Dose

February 19th 2024

Apixaban and Aspirin Appear Equal Against Recurrent Stroke in Individuals with Cardiopathy/ image credit stroke ©Stockdevil/stock.adobe.com
Apixaban and Aspirin Appear Equal Against Recurrent Stroke in Individuals with Cardiopathy

February 12th 2024

Apixaban Reduced Risk of Stroke in Subclinical Afib Relative to Aspirin but with Greater Risk of Bleeding: ARTRESIA Trial / image: Jeff Healy, MD
Apixaban Reduced Risk of Stroke in Subclinical Afib Relative to Aspirin but with Greater Risk of Bleeding: ARTRESIA Trial

February 2nd 2024

COPD Exacerbations May Increase Risk of Severe CV Events by More Than 15-Fold: Cohort Study / image credit heart and lungs ©Morphart Creation/shutterstock.com
COPD Exacerbations May Increase Risk of Severe CV Events by More Than 15-Fold: Cohort Study

January 10th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.